Vita 34 AG / Key word(s): Change of Personnel 01.08.2014 18:27 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Vita 34 AG: Management and supervisory board rely on continuity in the corporation - Management contract extended: Dr. André Gerth reappointed as CEO until 2018 - Internal changeover in supervisory board: Dr. Giering takes seat of chairman of supervisory board; previous chairman Dr. Födisch remains member of the board Leipzig, 1 August 2014 -Vita 34 AG (WKN A0BL84), the largest private stem cell bank in the German-speaking countries, provides for continuity in the corporation by reappointing Dr. André Gerth as CEO until 2018 and an internal changeover in the supervisory board. In today's meeting the supervisory board of Vita 34 AG has reappointed Dr. Gerth as the corporation's CEO from 1 August 2014 to 31 December 2018. The supervisory board thus expresses once again its confidence in Dr. Gerth and recognizes his previous performance as CEO of Vita 34 AG. Beyond that, Dr. Gerth emphasizes his commitment to Vita 34 AG by extending the lock-up agreement for his Vita 34 shares by another 18 months. The management board appreciates Dr. Gerth's clear proof of confidence. At the same time, the supervisory board elected Dr. Hans-Georg Giering, so far vice chairman of the supervisory board, the new chairman. He takes over the position from Dr. Holger Födisch with immediate effect. Dr. Giering has approved expertise from acting as the CEO of a quoted, successful company for almost 15 years. He will contribute this experience to his new position as the chairman of the supervisory board at Vita 34 AG. Dr. Födisch will continue to actively support the corporation as vice chairman of the supervisory board in the future. 01.08.2014 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: Vita 34 AG Deutscher Platz 5a 04103 Leipzig Germany Phone: +49(0341)48792-40 Fax: +49(0341)48792-39 E-mail: ir@vita34.de Internet: www.vita34.de ISIN: DE000A0BL849 WKN: A0BL84 Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, Düsseldorf, Hamburg, München, Stuttgart End of Announcement DGAP News-Service ---------------------------------------------------------------------------
DGAP-Adhoc: Vita 34 AG: Management and supervisory board
Top 10 Most Recent News Articles
APEC Summit 2026: Shenzhen in the Spotlight
An International Stage for Shenzhen Alright, folks, here's the deal. We’ve got the 2026 APEC Summit rolling into Shenzhen, perched right there in Guangdong Province, and the world’s eyes are glued to it. Happens November 18–19, and you better believe it’s a magnet for all things global. The China Media Group’s Chinese Global Program Center isn’t missing a...
Continue Reading
Innovent Unveils IAR177: A New Era In Rheumatology
Setting the Stage for Rheumatic Disease Breakthroughs Innovent Biologics is coming out of the gates hot with its recent presentation at the ACR Convergence 2026, delivering some jaw-dropping preclinical data on its fledgling bispecific antibody, IAR177. Situated in Orlando, this showcase sounds like a real advancement in tackling the uphill battle of rheumatic diseases....
Continue Reading
Azitra Reports Q3 2026: Key Developments in Biopharma Pipeline
Unpacking Azitra's Recent Breakthroughs Azitra, Inc. galloped into the spotlight with their Q3 2026 financials and some hefty business updates. This isn’t just about dollars and cents; they've got some fascinating biotech news wrapped in. Riding High on ATR-COSF Ex Vivo Results All eyes are on Azitra’s ATR-COSF. The lab is lighting up with news — a 50% wrinkle...
Continue Reading
SOCSA: The Future of Safety in Confined Spaces?
Autonomous Tech Meets Safety Regulations Some days innovation hits like a ton of bricks, and here we go again—this time with a gizmo aiming to shake up the safety game in confined spaces. Enter the SOCSA, the Self Operating Confined Space Attendant, designed by a seasoned agriculture worker who's had a ringside seat to enough OSHA rule breaches to fill a book. But ain't...
Continue Reading
Biointron's RushDATA™: Speeding Up Antibody Discovery
A New Chapter in Antibody Discovery Well, color me intrigued. Biointron, a name you'd recognize if you've got even a toe in the biotech pond, just threw a serious curveball into the antibody discovery game with RushDATA™—an AI- and machine learning-driven platform that's packing a punch. And it's not just about throwing tech buzzwords around; this thing clocks...
Continue Reading
SPOC Energy's Hiring Push Signals Growth Surge
A Growing Workforce for a Growing Demand Here we are, smack dab in a bustling week of business news, and among it, SPOC Energy is ramping up its workforce across Alabama. Now, SPOC isn't any run-of-the-mill operation; this Birmingham-based manufacturer messes around with advanced power conversion systems and motor-control automation—a mouthful, sure, but critical stuff...
Continue Reading
Golden State Dermatology Expands with Sparks Clinic Launch
Northern Nevada's New Name in Dermatology Take a stroll down Ion Drive in Sparks, and you'll find a fresh face in town—and we're not talking about a new coffee shop. Nope, it's something with a lot more skin in the game. Golden State Dermatology (GSD) is setting up shop at 5070 Ion Drive, Suite 201, and the doors are wide open for locals seeking dermatological care. A...
Continue Reading
Genesis One Rolls Out Telehealth Wellness Platform
Genesis One Enters the Fray with Home-Based Wellness In a health industry where everyone's screaming for transparency and flexibility, Genesis One is finding a sweet spot. They're throwing their hat in the ring with a new telehealth wellness pitch. Now, this isn't your everyday launch—it's a prelude to a January 2027 rollout, with co-founders Brent Messer and Dr. Alex...
Continue Reading
Koppers Faces SEC Scrutiny After Earnings Miss
Koppers' Third-Quarter Blues: Missing the Mark Koppers Holdings Inc. (NYSE: KOP) took a hard hit this quarter, missing Wall Street's earnings expectations by a mile. The adjusted earnings per share came in at just $0.77, while the suits down on Wall Street were expecting something closer to $1.34 to $1.37. Now, if you’re holding KOP in your portfolio, you're probably...
Continue Reading
Paris Baguette Opens New Café in Novato, CA
Another Feather in Paris Baguette’s Cap Alright, as far as pastry shops go, Paris Baguette is rolling out those cinnamon rolls like they're planting flags on the moon. They've just added a new café in Novato, California, bringing the artisanal charm of their iconic baked goods to yet another American doorstep. A Local Affair with Big Aspirations The man of the hour,...
Continue ReadingTop 5 Most Recently Viewed Articles
Tesla's Innovative Response to California Wildfires Using Tech
Tesla's Commitment to Community Support During Wildfires Tesla Inc (NASDAQ: TSLA) has recently made headlines for its proactive measures in response to wildfires devastating parts of California. CEO Elon Musk announced that the company's efforts would impact the delivery of Cybertrucks, which are highly anticipated by customers in the affected areas. The decision to delay...
Continue Reading
Aegon's Strong Q3 2024 Performance and Future Outlook
Aegon's Impressive Performance in the Third Quarter Aegon has recently shared compelling updates about its performance in the third quarter of 2024, showcasing resilience and strategic growth plans despite fluctuating market conditions. The company reported an impressive operating capital generation of EUR 336 million, which reinforces its robust financial position and...
Continue Reading
Anticipating Earnings: The Future of Ribbon Communications
Earnings Projection for Ribbon Communications Ribbon Communications (NASDAQ:RBBN) is gearing up to unveil its quarterly earnings report soon. Investors are watching closely, seeking signs that the company has not only met but exceeded expectations. According to forecasts, analysts predict an earnings per share (EPS) of approximately $0.05. This announcement is set to stir...
Continue Reading
Investors Urged to Examine Simulations Plus, Inc. Concerns
Investigating Simulations Plus, Inc. for Securities Fraud Recent events have raised significant concerns regarding the financial practices of Simulations Plus, Inc. (NASDAQ: SLP), a prominent software firm specializing in the pharmaceutical and biotechnology sectors. This article explores the unfolding situation, which has financial implications for investors closely...
Continue Reading
NEXE Innovations Showcases Growth and Milestones in Food Safety
NEXE Innovations Reports Strong Growth and Key Milestones NEXE Innovations Inc. (TSXV: NEXE) has recently released its financial results for the quarter that ended in August 2025. The company is making strides in the compostable materials sector and has showcased impressive growth metrics and operational achievements. Financial Highlights for Q1 2026 For the three-month...
Continue Reading